$0.4200
At close: Mar 28, 5:00 PM EST
$0.9590
0.54128.33%
After Hours: Oct 20, 4:00 PM EST
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. Analyst Ratings
ATXIOTCID
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. Analyst Ratings and Price Targets | OTC:ATXI | Benzinga
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. has a consensus price target of $0.75 based on the ratings of 1 analysts. The high is $0.75 issued by Maxim Group on December 11, 2023. The low is $0.75 issued by Maxim Group on December 11, 2023. The 1 most-recent analyst ratings were released by Maxim Group on December 11, 2023, respectively. With an average price target of $0.75 between Maxim Group, there's an implied -21.79% downside for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
1calculated from analyst ratings
Analyst Ratings for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc.
Loading calendar...
FAQ
What is the target price for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) stock?
The latest price target for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID:ATXI) was reported by Maxim Group on December 11, 2023. The analyst firm set a price target for $0.75 expecting ATXI to rise to within 12 months (a possible 150.00% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI)?
The latest analyst rating for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID:ATXI) was provided by Maxim Group, and AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. initiated their buy rating.
When was the last upgrade for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI)?
There is no last upgrade for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc.
When was the last downgrade for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI)?
There is no last downgrade for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
When is the next analyst rating going to be posted or updated for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc., and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. was filed on December 11, 2023 so you should expect the next rating to be made available sometime around December 11, 2024.
Is the Analyst Rating AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) correct?
While ratings are subjective and will change, the latest AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) rating was a initiated with a price target of $0.00 to $0.75. The current price AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) is trading at is $0.30, which is within the analyst’s predicted range.
